[Therapeutic tactics in the association of acute cholecystitis and obesity].
From experience in the treatment of 326 patients with acute cholecystitis and concomitant obesity the authors discuss the causes of unfavourable outcomes and plan the means for improving the results. Postoperative suppuration of the wound occurred in 31.5% of cases, and was encountered most frequently in patients who underwent emergency and urgent operations. It was established that concomitant obesity in patients with acute cholecystitis is a factor raising the risk of postoperative pyo-inflammatory complications. The immune status was found to be significantly depressed. Preoperative immunoprophylaxis should be applied to prevent pyo-inflammatory complications after the operation.
Magomedov
A Z
AZ
Kishov
M G
MG
Ashurlaev
K M
KM
D000208:Acute Disease; D000328:Adult; D000368:Aged; D002763:Cholecystectomy; D002764:Cholecystitis / Q000150:complications* / Q000276:immunology / Q000601:surgery; D004630:Emergencies; D005260:Female; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications* / Q000276:immunology; D011183:Postoperative Complications / Q000517:prevention & control; D011354:Prodigiozan / Q000627:therapeutic use
D007978:Levamisole; D011354:Prodigiozan
Lechebnaia taktika pri sochetanii ostrogo kholetsistita s ozhireniem.